NCT03887936View on ClinicalTrials.gov

Testosterone Therapy and Bone Quality in Men With Diabetes and Hypogonadism

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

October 1, 2019

Primary Completion Date

October 31, 2025

Study Completion Date

December 31, 2025

Conditions
Type 2 Diabetes MellitusHypogonadism
Interventions
DRUG

Testosterone gel 1.62%

Testosterone gel 1.62%, apply 2 pumps to upper arm and shoulder.

DRUG

Placebo

Matching placebo gel, apply 2 pumps to upper arm and shoulder

Trial Locations (1)

77030-4211

Michael E. DeBakey VA Medical Center, Houston, TX, Houston

All Listed Sponsors
lead

VA Office of Research and Development

FED